The International Cooperation Department of the China Securities Regulatory Commission issued a notice regarding the overseas issuance and listing of Ted Pharmaceutical (Zhejiang) Co., Ltd. and the "full circulation" registration of unlisted shares in China. The company plans to issue no more than 48,172,600 shares of overseas listed common stock and list them on the Hong Kong Stock Exchange. The company's 11 shareholders intend to convert a total of 56,798,888 shares of unlisted shares in China into overseas listed shares and list them on the Hong Kong Stock Exchange for trading.
证监会发布泰德医药境外发行上市及境内未上市股份“全流通”备案通知书
The CSRC issued a notice of "full circulation" registration for the overseas issuance and listing of Ted Pharmaceutical's unlisted shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated